Mario   Sznol, MD

Mario Sznol, MD

Yale Cancer Center/Smilow Cancer Hospital

Professor of Medicine (Medical Oncology); Clinical Research Leader, Melanoma Program; Co-Leader, Cancer Immunology, Yale Cancer Center; Co-Director, Yale SPORE in Skin Cancer

Expertise: Medical OncologyCancer ImmunologyMelanoma

Dr. Mario Sznol is a Professor of Medicine (Medical Oncology). Dr. Sznol, formerly with the National Cancer Institute, has an international reputation in cancer drug development. Dr. Sznol's expertise and experience is in cancer immunotherapy, drug development for cancer, and treatment of patients with melanoma and renal cell carcinoma. He is working to expand the opportunities for clinical trials at the Yale Cancer Center, particularly those focusing on immunotherapy and novel agents.

Education & Training:
Fellow-Mount Sinai College of Medicine (1987)
Resident-Baylor College of Medicine (1985)
MD-Baylor College of Medicine (1982)
BA-Rice University (1979)

No Clipping

No Research/Citations

Immunotherapy for metastatic cancer on the rise, even near end of life

A new study led by Yale Cancer Center researchers at Yale School of Medicine found that while the initiation of immunotherapy near the end of life has increased over time, a closer look at the benefit and value of these therapies in patients with advanced-stage disease is needed.
04-Jan-2024 12:05:42 PM EST

No Quotes

Available for logged-in users onlyLogin HereorRegister

No Video

close
0.08564